Replay available

Vitrolife AB (publ) (VITR) Q1 2025 Earnings Call

Vitrolife AB (publ) (STO: VITR) Q1 2025 earnings conference call, held 2025-04-24. Replay captured from the company's public earnings webcast.

Thu, April 24, 2025 at 4:00 AMendedReplay
Vitrolife AB (publ) (VITR) Q1 2025 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Bronwyn Broughy-O'Connor

CEO, Vitralife Group

Helena Wennerstrom

Acting CFO, Vitralife Group

Jacob Lemke

Analyst, SEB

David Johansson

Analyst, Nordea

Ulrich Fretner

Analyst, Carnegie

Philip Ikenren

Analyst, ABG/Sandal Collier

Susannah Quikberg

Analyst, Hondas Banking (SHB)

Johan Lleras

Analyst, Red Eye

Replay transcript excerpt

Hello and welcome to the Virtual Life Group Interim Report Q1 2025. My name is Laura and I'll be your coordinator for today's event. Please note this call is being recorded and for the duration of the call your lines will be on listen only mode. However, you will have the opportunity to ask questions at the end of the call. This can be done by pressing star 1 on your telephone keypad to register a question. If you require assistance at any point, please press star zero and you will be connected to an operator. I will now hand you over to your host, Bronwyn Broughy-O'Connor, to begin today's conference. Thank you. Thank you and good morning, everyone. This is Bronwyn Broughy-O'Connor, CEO of the Vitralife Group, speaking, and I'm joined by Helena Wennerstrom, the Acting CFO of the Vitralife Group. So, thank you for joining. I would like to move you to the first page and start with the Q1 2025 highlights. So starting with our largest region, which is EMEA, we delivered 14% growth in EMEA when excluding discounted business. So really strong performance in our largest region, and it's actually across the board in that region, all markets. Second point I would like to highlight is Americas, so growth of 9% in Americas driven by strong performance in North America. Most of you will be aware that we have been doubling down in the U.S. and North America. A lot of our efforts have been going in there over the past 12 months, so it's nice to see us starting to reap the benefits of those investments. And then the third point is we've strengthened our organizational structure. As a company, we have three main strategic priorities, growth, innovation, and operational excellence. So clearly, operational excellence and innovation, very strong priorities for the company. And we appo...

More from Vitrolife Ab